The Hidden Link of Exosomes to Head and Neck Cancer

Yong Teng1, Lixia Gao2, Reid Loveless3

  • 1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.

Cancers
|November 27, 2021
PubMed

Insights

Exosomes, small vesicles carrying molecules, promote head and neck squamous cell carcinoma (HNSCC) progression and drug resistance. Understanding exosome roles offers new therapeutic strategies for HNSCC patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer with poor patient survival rates.
  • Exosomes, nanoscale extracellular vesicles, are increasingly recognized for their role in intercellular communication and cancer progression.
  • Current therapeutic strategies for HNSCC have limited efficacy, necessitating novel treatment approaches.

Purpose of the Study:

  • To review the tumor-promoting roles of exosomes in HNSCC.
  • To explore the therapeutic potential of exosomes in HNSCC treatment and diagnosis.
  • To elucidate the mechanisms by which exosomes influence HNSCC aggressiveness.

Main Methods:

  • Literature review of studies on exosome biogenesis, composition, and function in HNSCC.
  • Analysis of exosome involvement in HNSCC proliferation, metastasis, and drug resistance.
  • Evaluation of exosome-based biomarkers and therapeutic applications in HNSCC.

Main Results:

  • Exosomes facilitate HNSCC progression by transferring oncogenic molecules and influencing the tumor microenvironment.
  • HNSCC-derived exosomes contribute to tumor drug resistance.
  • Exosomes show potential as biomarkers for HNSCC diagnosis and as carriers for targeted drug delivery.

Conclusions:

  • Exosomes play a significant role in supporting HNSCC aggressiveness and mediating therapeutic resistance.
  • Targeting exosome pathways presents a promising avenue for novel HNSCC treatments.
  • Exosomes hold potential as diagnostic biomarkers and drug delivery vehicles for HNSCC.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K